Let's say the licensing agreement is 80% - which is very high considering RXI is doing the development. And, if Samcyprone works as anticipated, it gains 25% market share. RXI would collect $10M annually. These are extremely conservative guesstimates. What does that alone value RXII at? $80M market cap for this application alone?